Healthcare provider profile · identity verified

Tung Tran, M.D.

Family Practice · WOODLAND HILLS, CA · NPI 1124361910

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	734	301
Lisinopril	Lisinopril	466	184
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	400	112
Amlodipine Besylate	Amlodipine Besylate	316	135
Losartan Potassium	Losartan Potassium	312	119
Levothyroxine Sodium	Levothyroxine Sodium	281	104
Metformin Hcl	Metformin Hcl	242	100
Atenolol	Atenolol	212	84
Omeprazole	Omeprazole	198	89
Albuterol Sulfate Hfa	Albuterol Sulfate	184	91
Potassium Chloride	Potassium Chloride	184	82
Meloxicam	Meloxicam	166	66
Gabapentin	Gabapentin	160	76
Metformin Hcl Er	Metformin Hcl	153	71
Simvastatin	Simvastatin	152	63
Furosemide	Furosemide	142	53
Rosuvastatin Calcium	Rosuvastatin Calcium	140	59
Ibuprofen	Ibuprofen	139	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	138	60
Glipizide	Glipizide	133	51
Alendronate Sodium	Alendronate Sodium	129	55
Hydrochlorothiazide	Hydrochlorothiazide	128	56
Pantoprazole Sodium	Pantoprazole Sodium	125	38
Pradaxa	Dabigatran Etexilate Mesylate	120	45
Tamsulosin Hcl	Tamsulosin Hcl	118	49
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	102	30
Trazodone Hcl	Trazodone Hcl	102	35
Terazosin Hcl	Terazosin Hcl	101	41
Metoprolol Tartrate	Metoprolol Tartrate	93	40
Ondansetron Odt	Ondansetron	89	29
Jardiance	Empagliflozin	87	38
Bisoprolol Fumarate	Bisoprolol Fumarate	86	32
Allopurinol	Allopurinol	85	35
Humulin N	Insulin Nph Human Isophane	68	26
Wixela Inhub	Fluticasone Propion/Salmeterol	68	36
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	64	26
Naproxen	Naproxen	63	30
Alvesco	Ciclesonide	57	33
Hydralazine Hcl	Hydralazine Hcl	57	23
Azelastine Hcl	Azelastine Hcl	55	21
Prednisone	Prednisone	55	36
Hydrocortisone	Hydrocortisone	54	20
Sumatriptan Succinate	Sumatriptan Succinate	54	12
Mirtazapine	Mirtazapine	53	24
Cephalexin	Cephalexin	52	41
Spironolactone	Spironolactone	50	20
Tramadol Hcl	Tramadol Hcl	50	20
Sertraline Hcl	Sertraline Hcl	49	25
Lorazepam	Lorazepam	48	22
Pregabalin	Pregabalin	48	14
Alprazolam	Alprazolam	47	suppressed
Morphine Sulfate Er	Morphine Sulfate	47	suppressed
Acyclovir	Acyclovir	45	12
Doxycycline Monohydrate	Doxycycline Monohydrate	44	25
Finasteride	Finasteride	44	16
Triamcinolone Acetonide	Triamcinolone Acetonide	44	29
Humulin R	Insulin Regular, Human	43	17
Baclofen	Baclofen	42	12
Famotidine	Famotidine	37	17
Fluticasone Propionate	Fluticasone Propionate	34	suppressed
Temazepam	Temazepam	34	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	33	33
Lactulose	Lactulose	32	15
Ondansetron Hcl	Ondansetron Hcl	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	17
Montelukast Sodium	Montelukast Sodium	31	21
Carvedilol	Carvedilol	30	15
Ozempic	Semaglutide	30	suppressed
Liraglutide	Liraglutide	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	12
Spiriva Respimat	Tiotropium Bromide	27	suppressed
Propranolol Hcl	Propranolol Hcl	26	13
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	26	14
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	25	25
Estradiol	Estradiol	25	suppressed
Mupirocin	Mupirocin	25	20
Methocarbamol	Methocarbamol	24	11
Metoprolol Succinate	Metoprolol Succinate	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Naloxone Hcl	Naloxone Hcl	19	12
Valacyclovir	Valacyclovir Hcl	19	suppressed
Victoza 2-Pak	Liraglutide	19	suppressed
Amoxicillin	Amoxicillin	18	18
Humulin N Kwikpen	Insulin Nph Human Isophane	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Topiramate	Topiramate	17	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	16	suppressed
Ciclopirox	Ciclopirox	15	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Victoza 3-Pak	Liraglutide	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Tacrolimus	Tacrolimus	12	suppressed
Testosterone	Testosterone	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error